News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SIDMAP Technology Used to Characterize Novel Drug for Type 2 Diabetes


7/21/2010 9:02:56 AM

LOS ANGELES--(BUSINESS WIRE)--SiDMAP, LLC (www.sidmap.com), a privately held life-science company that provides metabolomics research services to the pharmaceutical and biotechnology industries and the academic biomedical research community worldwide, announced today results of a study conducted in collaboration with scientists at Roche (Nutley, NJ), a leading pharmaceutical company, on a novel Roche drug for Type 2 diabetes.

Read at BioSpace.com


comments powered by Disqus
SIDMAP
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES